Poland· PL-100057468
Reasec
A diphenoxylate product containing diphenoxylati hydrochloridum + atropini sulfas, registered in Poland by Gedeon Richter Plc.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Diphenoxylate is registered in 4 of 19 countries.
Countries holding a registration under ATC A07DA01 (diphenoxylate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Diphenoxylate · ATC A07DA01
4 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Diphenoxylati hydrochloridum + Atropini sulfas
- Manufacturer
- Gedeon Richter Plc.
- Country
- Poland (PL)
- ATC code
- A07DA01
- ATC class
- Diphenoxylate
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990254415
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
73 interactions on record for diphenoxylate.
Graded by severity as the source publishes them — 73 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diphenoxylate · interactions on record
73 records
- 73 moderate
Most severe, free to view
- NabiloneA04AD11moderate
- EthanolB05XX04moderate
- BrimonidineD11AX21moderate
- BromocriptineG02CB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Diphenoxylate in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDiphenoxylate hydrochloride and atropine sulfateChartwell RX, LLC
- CanadaLOMOTILPFIZER CANADA ULC
- CzechiaREASECGedeon Richter Plc., Budapešť
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Cyprus · Lomotil
- Czechia · Reasec
- Hungary · Reasec
- Slovakia · Reasec
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c996c30d-f3e7-42b5-9a74-e0982b418d3a GET /v1/drugs/c996c30d-f3e7-42b5-9a74-e0982b418d3a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "2,5 mg + 25 mcg",
"packaging": "05909990254415 ¦ Rp ¦ 8577\n20 tabl.",
"substance": "Diphenoxylati hydrochloridum 2.5 mg + Atropini sulfas 0.025 mg",
"common_name": "Diphenoxylati hydrochloridum + Atropini sulfas",
"pl_product_id": "100057468",
"pozwolenie_nr": "02544",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about diphenoxylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.